APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phage Therapy

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

Selected research

Market Structure

Global Phage Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025191 pages

Choose your research edition.

Industry ResearchPhage Therapy Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Phage Therapy Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Phage Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phage Therapy Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Phage Therapy Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.

Report Includes

Read the full market overview

This report provides an overview of the global Phage Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Phage Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Phage Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Phage Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Phage Therapy Segment by Company

NPO Microgen

Proteon Pharmaceuticals

Phagelux

Intralytix

Micreos

Eliava BioPreparations

Locus Biosciences,Inc

Pharmex Group,LLC

Pherecydes Pharma

APS Biocontrol Ltd. (APS)

Qingdao Phagepharm Bio-tech

Fixed-Phage Limited

Zeptometrix

Phage International, Inc.

MicroMir

iNtODEWORLD, Inc.

NEXTBIOTICS

Armata Pharmaceuticals, Inc.

Innophage

Adaptive Phage Therapeutics

TechnoPhage

Phage Therapy Segment by Type

DsDNA Bacteriophage

SsDNA Bacteriophage

SsRNA Bacteriophage

Others

Phage Therapy Segment by Application

Animal Health

Aquaculture

Agriculture

Food Industry

Human Health

Others

Phage Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phage Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phage Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phage Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Phage Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Phage Therapy industry.

Chapter 3: Detailed analysis of Phage Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Phage Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Phage Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of DsDNA Bacteriophage Table 3. Key Players of SsDNA Bacteriophage Table 4. Key Players of SsRNA Bacteriophage Table 3. Key Players of Others Table 4. Global Phage Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Animal Health Table 6. Key Players of Aquaculture Table 7. Key Players of Agriculture Table 8. Key Players of Food Industry Table 9. Key Players of Human Health Table 10. Key Players of Others Table 11. Global Phage Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Phage Therapy Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Phage Therapy Market Share by Region (2021-2026) Table 14. Global Phage Therapy Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Phage Therapy Market Share by Region (2027-2032) Table 16. Phage Therapy Industry Trends Table 17. Phage Therapy Industry Drivers Table 18. Phage Therapy Industry Opportunities and Challenges Table 19. Phage Therapy Industry Restraints Table 20. Global Phage Therapy Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Phage Therapy Revenue Market Share by Company (2021-2026) Table 22. Global Phage Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Phage Therapy Key Company Head Office and Area Served Table 24. Global Phage Therapy Company, Product Type & Application Table 25. Global Phage Therapy Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Phage Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Phage Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Phage Therapy Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Phage Therapy Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Phage Therapy Revenue Market Share by Type (2021-2026) Table 32. Global Phage Therapy Revenue Market Share by Type (2027-2032) Table 33. Global Phage Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Phage Therapy Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Phage Therapy Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Phage Therapy Revenue Market Share by Application (2021-2026) Table 37. Global Phage Therapy Revenue Market Share by Application (2027-2032) Table 38. NPO Microgen Company Information Table 39. NPO Microgen Business Overview Table 40. NPO Microgen Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. NPO Microgen Phage Therapy Product Portfolio Table 42. NPO Microgen Recent Development Table 43. Proteon Pharmaceuticals Company Information Table 44. Proteon Pharmaceuticals Business Overview Table 45. Proteon Pharmaceuticals Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Proteon Pharmaceuticals Phage Therapy Product Portfolio Table 47. Proteon Pharmaceuticals Recent Development Table 48. Phagelux Company Information Table 49. Phagelux Business Overview Table 50. Phagelux Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Phagelux Phage Therapy Product Portfolio Table 52. Phagelux Recent Development Table 53. Intralytix Company Information Table 54. Intralytix Business Overview Table 55. Intralytix Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Intralytix Phage Therapy Product Portfolio Table 57. Intralytix Recent Development Table 58. Micreos Company Information Table 59. Micreos Business Overview Table 60. Micreos Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Micreos Phage Therapy Product Portfolio Table 62. Micreos Recent Development Table 63. Eliava BioPreparations Company Information Table 64. Eliava BioPreparations Business Overview Table 65. Eliava BioPreparations Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Eliava BioPreparations Phage Therapy Product Portfolio Table 67. Eliava BioPreparations Recent Development Table 68. Locus Biosciences,Inc Company Information Table 69. Locus Biosciences,Inc Business Overview Table 70. Locus Biosciences,Inc Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Locus Biosciences,Inc Phage Therapy Product Portfolio Table 72. Locus Biosciences,Inc Recent Development Table 73. Pharmex Group,LLC Company Information Table 74. Pharmex Group,LLC Business Overview Table 75. Pharmex Group,LLC Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Pharmex Group,LLC Phage Therapy Product Portfolio Table 77. Pharmex Group,LLC Recent Development Table 78. Pherecydes Pharma Company Information Table 79. Pherecydes Pharma Business Overview Table 80. Pherecydes Pharma Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Pherecydes Pharma Phage Therapy Product Portfolio Table 82. Pherecydes Pharma Recent Development Table 83. APS Biocontrol Ltd. (APS) Company Information Table 84. APS Biocontrol Ltd. (APS) Business Overview Table 85. APS Biocontrol Ltd. (APS) Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. APS Biocontrol Ltd. (APS) Phage Therapy Product Portfolio Table 87. APS Biocontrol Ltd. (APS) Recent Development Table 88. Qingdao Phagepharm Bio-tech Company Information Table 89. Qingdao Phagepharm Bio-tech Business Overview Table 90. Qingdao Phagepharm Bio-tech Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. Qingdao Phagepharm Bio-tech Phage Therapy Product Portfolio Table 92. Qingdao Phagepharm Bio-tech Recent Development Table 93. Fixed-Phage Limited Company Information Table 94. Fixed-Phage Limited Business Overview Table 95. Fixed-Phage Limited Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 96. Fixed-Phage Limited Phage Therapy Product Portfolio Table 97. Fixed-Phage Limited Recent Development Table 98. Zeptometrix Company Information Table 99. Zeptometrix Business Overview Table 100. Zeptometrix Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 101. Zeptometrix Phage Therapy Product Portfolio Table 102. Zeptometrix Recent Development Table 103. Phage International, Inc. Company Information Table 104. Phage International, Inc. Business Overview Table 105. Phage International, Inc. Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 106. Phage International, Inc. Phage Therapy Product Portfolio Table 107. Phage International, Inc. Recent Development Table 108. MicroMir Company Information Table 109. MicroMir Business Overview Table 110. MicroMir Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 111. MicroMir Phage Therapy Product Portfolio Table 112. MicroMir Recent Development Table 113. iNtODEWORLD, Inc. Company Information Table 114. iNtODEWORLD, Inc. Business Overview Table 115. iNtODEWORLD, Inc. Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 116. iNtODEWORLD, Inc. Phage Therapy Product Portfolio Table 117. iNtODEWORLD, Inc. Recent Development Table 118. NEXTBIOTICS Company Information Table 119. NEXTBIOTICS Business Overview Table 120. NEXTBIOTICS Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 121. NEXTBIOTICS Phage Therapy Product Portfolio Table 122. NEXTBIOTICS Recent Development Table 123. Armata Pharmaceuticals, Inc. Company Information Table 124. Armata Pharmaceuticals, Inc. Business Overview Table 125. Armata Pharmaceuticals, Inc. Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 126. Armata Pharmaceuticals, Inc. Phage Therapy Product Portfolio Table 127. Armata Pharmaceuticals, Inc. Recent Development Table 128. Innophage Company Information Table 129. Innophage Business Overview Table 130. Innophage Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 131. Innophage Phage Therapy Product Portfolio Table 132. Innophage Recent Development Table 133. Adaptive Phage Therapeutics Company Information Table 134. Adaptive Phage Therapeutics Business Overview Table 135. Adaptive Phage Therapeutics Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 136. Adaptive Phage Therapeutics Phage Therapy Product Portfolio Table 137. Adaptive Phage Therapeutics Recent Development Table 138. TechnoPhage Company Information Table 139. TechnoPhage Business Overview Table 140. TechnoPhage Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 141. TechnoPhage Phage Therapy Product Portfolio Table 142. TechnoPhage Recent Development Table 143. North America Phage Therapy Market Size by Type (2021-2026) & (US$ Million) Table 144. North America Phage Therapy Market Size by Type (2027-2032) & (US$ Million) Table 145. North America Phage Therapy Market Size by Application (2021-2026) & (US$ Million) Table 146. North America Phage Therapy Market Size by Application (2027-2032) & (US$ Million) Table 147. North America Phage Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. North America Phage Therapy Market Size by Country (2021-2026) Table 149. North America Phage Therapy Market Size by Country (2027-2032) Table 150. Europe Phage Therapy Market Size by Type (2021-2026) & (US$ Million) Table 151. Europe Phage Therapy Market Size by Type (2027-2032) & (US$ Million) Table 152. Europe Phage Therapy Market Size by Application (2021-2026) & (US$ Million) Table 153. Europe Phage Therapy Market Size by Application (2027-2032) & (US$ Million) Table 154. Europe Phage Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Europe Phage Therapy Market Size by Country (2021-2026) Table 156. Europe Phage Therapy Market Size by Country (2027-2032) Table 157. China Phage Therapy Market Size by Type (2021-2026) & (US$ Million) Table 158. China Phage Therapy Market Size by Type (2027-2032) & (US$ Million) Table 159. China Phage Therapy Market Size by Application (2021-2026) & (US$ Million) Table 160. China Phage Therapy Market Size by Application (2027-2032) & (US$ Million) Table 161. Asia Phage Therapy Market Size by Type (2021-2026) & (US$ Million) Table 162. Asia Phage Therapy Market Size by Type (2027-2032) & (US$ Million) Table 163. Asia Phage Therapy Market Size by Application (2021-2026) & (US$ Million) Table 164. Asia Phage Therapy Market Size by Application (2027-2032) & (US$ Million) Table 165. Asia Phage Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Asia Phage Therapy Market Size by Country (2021-2026) Table 167. Asia Phage Therapy Market Size by Country (2027-2032) Table 168. South America, Middle East & Africa Phage Therapy Market Size by Type (2021-2026) & (US$ Million) Table 169. South America, Middle East & Africa Phage Therapy Market Size by Type (2027-2032) & (US$ Million) Table 170. South America, Middle East & Africa Phage Therapy Market Size by Application (2021-2026) & (US$ Million) Table 171. South America, Middle East & Africa Phage Therapy Market Size by Application (2027-2032) & (US$ Million) Table 172. South America, Middle East & Africa Phage Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. South America, Middle East & Africa Phage Therapy Market Size by Country (2021-2026) Table 174. South America, Middle East & Africa Phage Therapy Market Size by Country (2027-2032) Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Phage Therapy Product Image Figure 2. Global Phage Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Phage Therapy Market Share by Type: 2025 VS 2032 Figure 4. DsDNA Bacteriophage Image Figure 5. SsDNA Bacteriophage Image Figure 6. SsRNA Bacteriophage Image Figure 7. Others Image Figure 8. Global Phage Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Phage Therapy Market Share by Application: 2025 VS 2032 Figure 10. Animal Health Image Figure 11. Aquaculture Image Figure 12. Agriculture Image Figure 13. Food Industry Image Figure 14. Human Health Image Figure 15. Others Image Figure 16. Global Phage Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 18. Global Phage Therapy Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Phage Therapy Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Phage Therapy Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Phage Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Phage Therapy Revenue Market Share by Type (2021-2032) Figure 25. Global Phage Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Phage Therapy Revenue Market Share by Application (2021-2032) Figure 27. North America Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 28. North America Phage Therapy Market Share by Type (2021-2032) Figure 29. North America Phage Therapy Market Share by Application (2021-2032) Figure 30. North America Phage Therapy Market Share by Country (2021-2032) Figure 31. United States Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 32. Canada Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 34. Europe Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 35. Europe Phage Therapy Market Share by Type (2021-2032) Figure 36. Europe Phage Therapy Market Share by Application (2021-2032) Figure 37. Europe Phage Therapy Market Share by Country (2021-2032) Figure 38. Germany Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 39. France Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 41. Italy Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 42. Russia Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 44. China Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 45. China Phage Therapy Market Share by Type (2021-2032) Figure 46. China Phage Therapy Market Share by Application (2021-2032) Figure 47. Asia Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 48. Asia Phage Therapy Market Share by Type (2021-2032) Figure 49. Asia Phage Therapy Market Share by Application (2021-2032) Figure 50. Asia Phage Therapy Market Share by Country (2021-2032) Figure 51. Japan Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 55. India Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 56. Australia Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Phage Therapy Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Phage Therapy Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Phage Therapy Market Share by Country (2021-2032) Figure 61. Brazil Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 66. UAE Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 68. Chile Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • DsDNA Bacteriophage
  • SsDNA Bacteriophage
  • SsRNA Bacteriophage
  • Others
Applications
  • Animal Health
  • Aquaculture
  • Agriculture
  • Food Industry
  • Human Health
  • Others
Companies covered
  • NPO Microgen
  • Proteon Pharmaceuticals
  • Phagelux
  • Intralytix
  • Micreos
  • Eliava BioPreparations
  • Locus Biosciences,Inc
  • Pharmex Group,LLC
  • Pherecydes Pharma
  • APS Biocontrol Ltd. (APS)
  • Qingdao Phagepharm Bio-tech
  • Fixed-Phage Limited
  • Zeptometrix
  • Phage International, Inc.
  • MicroMir
  • iNtODEWORLD, Inc.
  • NEXTBIOTICS
  • Armata Pharmaceuticals, Inc.
  • Innophage
  • Adaptive Phage Therapeutics
  • TechnoPhage

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Phage Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 DsDNA Bacteriophage
  5. 1.2.3 SsDNA Bacteriophage
  6. 1.2.4 SsRNA Bacteriophage
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Phage Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Animal Health
  11. 1.3.3 Aquaculture
  12. 1.3.4 Agriculture
  13. 1.3.5 Food Industry
  14. 1.3.6 Human Health
  15. 1.3.7 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Phage Therapy Growth Trends by Region
  18. 1.5.1 Global Phage Therapy Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Phage Therapy Market Size by Region (2021-2026)
  20. 1.5.3 Phage Therapy Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Phage Therapy Market Dynamics
  1. 2.1 Phage Therapy Industry Trends
  2. 2.2 Phage Therapy Industry Drivers
  3. 2.3 Phage Therapy Industry Opportunities and Challenges
  4. 2.4 Phage Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Phage Therapy Revenue by Company (2021-2026)
  2. 3.2 Global Phage Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Phage Therapy Key Company Head office and Area Served
  4. 3.4 Global Phage Therapy Company, Product Type & Application
  5. 3.5 Global Phage Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Phage Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Phage Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Phage Therapy Tier 1, Tier 2, and Tier 3
4 Phage Therapy Market by Type
  1. 4.1 Global Phage Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Phage Therapy Market Size by Type (2021-2032)
  3. 4.3 Global Phage Therapy Market Size Share by Type (2021-2032)
5 Phage Therapy Market by Application
  1. 5.1 Global Phage Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Phage Therapy Market Size by Application (2021-2032)
  3. 5.3 Global Phage Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 NPO Microgen
  2. 6.1.1 NPO Microgen Company Information
  3. 6.1.2 NPO Microgen Business Overview
  4. 6.1.3 NPO Microgen Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 NPO Microgen Phage Therapy Product Portfolio
  6. 6.1.5 NPO Microgen Recent Developments
  7. 6.2 Proteon Pharmaceuticals
  8. 6.2.1 Proteon Pharmaceuticals Company Information
  9. 6.2.2 Proteon Pharmaceuticals Business Overview
  10. 6.2.3 Proteon Pharmaceuticals Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Proteon Pharmaceuticals Phage Therapy Product Portfolio
  12. 6.2.5 Proteon Pharmaceuticals Recent Developments
  13. 6.3 Phagelux
  14. 6.3.1 Phagelux Company Information
  15. 6.3.2 Phagelux Business Overview
  16. 6.3.3 Phagelux Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Phagelux Phage Therapy Product Portfolio
  18. 6.3.5 Phagelux Recent Developments
  19. 6.4 Intralytix
  20. 6.4.1 Intralytix Company Information
  21. 6.4.2 Intralytix Business Overview
  22. 6.4.3 Intralytix Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Intralytix Phage Therapy Product Portfolio
  24. 6.4.5 Intralytix Recent Developments
  25. 6.5 Micreos
  26. 6.5.1 Micreos Company Information
  27. 6.5.2 Micreos Business Overview
  28. 6.5.3 Micreos Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Micreos Phage Therapy Product Portfolio
  30. 6.5.5 Micreos Recent Developments
  31. 6.6 Eliava BioPreparations
  32. 6.6.1 Eliava BioPreparations Company Information
  33. 6.6.2 Eliava BioPreparations Business Overview
  34. 6.6.3 Eliava BioPreparations Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Eliava BioPreparations Phage Therapy Product Portfolio
  36. 6.6.5 Eliava BioPreparations Recent Developments
  37. 6.7 Locus Biosciences,Inc
  38. 6.7.1 Locus Biosciences,Inc Company Information
  39. 6.7.2 Locus Biosciences,Inc Business Overview
  40. 6.7.3 Locus Biosciences,Inc Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Locus Biosciences,Inc Phage Therapy Product Portfolio
  42. 6.7.5 Locus Biosciences,Inc Recent Developments
  43. 6.8 Pharmex Group,LLC
  44. 6.8.1 Pharmex Group,LLC Company Information
  45. 6.8.2 Pharmex Group,LLC Business Overview
  46. 6.8.3 Pharmex Group,LLC Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Pharmex Group,LLC Phage Therapy Product Portfolio
  48. 6.8.5 Pharmex Group,LLC Recent Developments
  49. 6.9 Pherecydes Pharma
  50. 6.9.1 Pherecydes Pharma Company Information
  51. 6.9.2 Pherecydes Pharma Business Overview
  52. 6.9.3 Pherecydes Pharma Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Pherecydes Pharma Phage Therapy Product Portfolio
  54. 6.9.5 Pherecydes Pharma Recent Developments
  55. 6.10 APS Biocontrol Ltd. (APS)
  56. 6.10.1 APS Biocontrol Ltd. (APS) Company Information
  57. 6.10.2 APS Biocontrol Ltd. (APS) Business Overview
  58. 6.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 APS Biocontrol Ltd. (APS) Phage Therapy Product Portfolio
  60. 6.10.5 APS Biocontrol Ltd. (APS) Recent Developments
  61. 6.11 Qingdao Phagepharm Bio-tech
  62. 6.11.1 Qingdao Phagepharm Bio-tech Company Information
  63. 6.11.2 Qingdao Phagepharm Bio-tech Business Overview
  64. 6.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Qingdao Phagepharm Bio-tech Phage Therapy Product Portfolio
  66. 6.11.5 Qingdao Phagepharm Bio-tech Recent Developments
  67. 6.12 Fixed-Phage Limited
  68. 6.12.1 Fixed-Phage Limited Company Information
  69. 6.12.2 Fixed-Phage Limited Business Overview
  70. 6.12.3 Fixed-Phage Limited Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Fixed-Phage Limited Phage Therapy Product Portfolio
  72. 6.12.5 Fixed-Phage Limited Recent Developments
  73. 6.13 Zeptometrix
  74. 6.13.1 Zeptometrix Company Information
  75. 6.13.2 Zeptometrix Business Overview
  76. 6.13.3 Zeptometrix Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Zeptometrix Phage Therapy Product Portfolio
  78. 6.13.5 Zeptometrix Recent Developments
  79. 6.14 Phage International, Inc.
  80. 6.14.1 Phage International, Inc. Company Information
  81. 6.14.2 Phage International, Inc. Business Overview
  82. 6.14.3 Phage International, Inc. Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Phage International, Inc. Phage Therapy Product Portfolio
  84. 6.14.5 Phage International, Inc. Recent Developments
  85. 6.15 MicroMir
  86. 6.15.1 MicroMir Company Information
  87. 6.15.2 MicroMir Business Overview
  88. 6.15.3 MicroMir Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 MicroMir Phage Therapy Product Portfolio
  90. 6.15.5 MicroMir Recent Developments
  91. 6.16 iNtODEWORLD, Inc.
  92. 6.16.1 iNtODEWORLD, Inc. Company Information
  93. 6.16.2 iNtODEWORLD, Inc. Business Overview
  94. 6.16.3 iNtODEWORLD, Inc. Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 iNtODEWORLD, Inc. Phage Therapy Product Portfolio
  96. 6.16.5 iNtODEWORLD, Inc. Recent Developments
  97. 6.17 NEXTBIOTICS
  98. 6.17.1 NEXTBIOTICS Company Information
  99. 6.17.2 NEXTBIOTICS Business Overview
  100. 6.17.3 NEXTBIOTICS Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 NEXTBIOTICS Phage Therapy Product Portfolio
  102. 6.17.5 NEXTBIOTICS Recent Developments
  103. 6.18 Armata Pharmaceuticals, Inc.
  104. 6.18.1 Armata Pharmaceuticals, Inc. Company Information
  105. 6.18.2 Armata Pharmaceuticals, Inc. Business Overview
  106. 6.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Armata Pharmaceuticals, Inc. Phage Therapy Product Portfolio
  108. 6.18.5 Armata Pharmaceuticals, Inc. Recent Developments
  109. 6.19 Innophage
  110. 6.19.1 Innophage Company Information
  111. 6.19.2 Innophage Business Overview
  112. 6.19.3 Innophage Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Innophage Phage Therapy Product Portfolio
  114. 6.19.5 Innophage Recent Developments
  115. 6.20 Adaptive Phage Therapeutics
  116. 6.20.1 Adaptive Phage Therapeutics Company Information
  117. 6.20.2 Adaptive Phage Therapeutics Business Overview
  118. 6.20.3 Adaptive Phage Therapeutics Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Adaptive Phage Therapeutics Phage Therapy Product Portfolio
  120. 6.20.5 Adaptive Phage Therapeutics Recent Developments
  121. 6.21 TechnoPhage
  122. 6.21.1 TechnoPhage Company Information
  123. 6.21.2 TechnoPhage Business Overview
  124. 6.21.3 TechnoPhage Phage Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 TechnoPhage Phage Therapy Product Portfolio
  126. 6.21.5 TechnoPhage Recent Developments
7 North America
  1. 7.1 North America Phage Therapy Market Size (2021-2032)
  2. 7.2 North America Phage Therapy Market Size by Type
  3. 7.2.1 North America Phage Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America Phage Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America Phage Therapy Market Share by Type (2021-2032)
  6. 7.3 North America Phage Therapy Market Size by Application
  7. 7.3.1 North America Phage Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America Phage Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America Phage Therapy Market Share by Application (2021-2032)
  10. 7.4 North America Phage Therapy Market Size by Country
  11. 7.4.1 North America Phage Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Phage Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America Phage Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America Phage Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Phage Therapy Market Size (2021-2032)
  2. 8.2 Europe Phage Therapy Market Size by Type
  3. 8.2.1 Europe Phage Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Phage Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Phage Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe Phage Therapy Market Size by Application
  7. 8.3.1 Europe Phage Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Phage Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Phage Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe Phage Therapy Market Size by Country
  11. 8.4.1 Europe Phage Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Phage Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Phage Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Phage Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Phage Therapy Market Size (2021-2032)
  2. 9.2 China Phage Therapy Market Size by Type
  3. 9.2.1 China Phage Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China Phage Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China Phage Therapy Market Share by Type (2021-2032)
  6. 9.3 China Phage Therapy Market Size by Application
  7. 9.3.1 China Phage Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China Phage Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China Phage Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Phage Therapy Market Size (2021-2032)
  2. 10.2 Asia Phage Therapy Market Size by Type
  3. 10.2.1 Asia Phage Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Phage Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Phage Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia Phage Therapy Market Size by Application
  7. 10.3.1 Asia Phage Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Phage Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Phage Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia Phage Therapy Market Size by Country
  11. 10.4.1 Asia Phage Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Phage Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Phage Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Phage Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Phage Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Phage Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Phage Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Phage Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Phage Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Phage Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Phage Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Phage Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Phage Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Phage Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Phage Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Phage Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Phage Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Phage Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst